Registration - Amendment

2019 2nd Quarter (Apr 1 - June 30) Amended Filing Foreign Entity
Income
—
Expenses
—
Official Senate LDA Document

Lobbying Activities

Biodefense; Biomedical Advanced Research and Development Authority funding, vaccine research, development, manufacturing and marketing; infectious diseases, cancer, Labor-HHS-ED appropriations bills
Lobbyists
Biodefense; Biomedical Advanced Research and Development Authority funding, vaccine research, development, manufacturing and marketing; infectious diseases, cancer, Labor-HHS-ED appropriations bills
Lobbyists
Biodefense; Biomedical Advanced Research and Development Authority funding, vaccine research, development, manufacturing and marketing; infectious diseases, cancer, Labor-HHS-ED appropriations bills
Lobbyists
Biodefense; Biomedical Advanced Research and Development Authority funding, vaccine research, development, manufacturing and marketing; infectious diseases, cancer, Labor-HHS-ED appropriations bills
Lobbyists
Biodefense; Biomedical Advanced Research and Development Authority funding, vaccine research, development, manufacturing and marketing; infectious diseases, cancer, Labor-HHS-ED appropriations bills
Lobbyists
Biodefense; Biomedical Advanced Research and Development Authority funding, vaccine research, development, manufacturing and marketing; infectious diseases, cancer, Labor-HHS-ED appropriations bills
Lobbyists
Biodefense; Biomedical Advanced Research and Development Authority funding, vaccine research, development, manufacturing and marketing; infectious diseases, cancer, Labor-HHS-ED appropriations bills
Lobbyists

Foreign Entities

BAVARIAN NORDIC A/S
Country: Denmark Contribution: $200,000 Ownership: 100.0%